2Gralla R,Harper P,Johnson S,et al.Vinorelbine(Navelbine) in the treatment of non-small-cell lung cancer : Studies with single-agent therapy and in combination with cisplatin[J].Ann Oncol,1999,10(12):1533-1537.
3Lacava JA, Leone BA, Machiavelli M, et al.Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma[J].J Clin Oncol,1997,15(2):604-609.
4Rittenberg CN, Gralla RJ, Rehmeyer TA, et al . Assessing and managing venous irritation associated with vinorelbine tartrate[J].Oncol Nurs Forum,1995,22(3):707-710.
5M Mare, R Maisano, N Caristi, et al.Veous damage prevention by defibrotide in vinorelbine-treated patients[J].Support Care Cancer,2003,11(9):593-596.
6Vassilomanolakis M, Koumakis G, Barbounis V, et al. Prevention of vinorelbine phlebitis with cimetidine. A two-stepdesign study[J].Support Care Cancer,2001, 9(2):108-111.
7Estevez MD,Vietyes MR,Louzano MC,et al.The antineopla-stic drug vinorelbine activates non-immunological histamine release from rat mast cells[J].Inflamm Res,1997,46(4):119-124.
8H J Nielsen.Possible effect of histamine-2 receptor blockade on the antitumour response to interrleukin-2[J].European Journal of Cancer,1995,31(9):1390-1391.
